LONDON, March 17, 2025 /PRNewswire/ -- The Institute for Portfolio Alternatives (IPA) is proud to announce the debut event of its new AltsGlobal conference series, set to take place from November ...
VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced ...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results